Biogen stock fall shows drug investment model is wrong: Ex-Aetna CEO

Investors need to change their approach to investing in pharmaceutical companies that are working to develop life-altering treatments, former Aetna Chairman and CEO Mark Bertolini told CNBC on Friday.

Source link

Leave a Comment

U.S. Customs details China pork seizure; importers could pay fineIVF ethics pioneer Mary Warnock dies